SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 140 filers reported holding SUTRO BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,454 | -35.6% | 2,148 | -13.7% | 0.00% | – |
| Q2 2023 | $11,579 | -20.3% | 2,490 | -20.8% | 0.00% | – |
| Q1 2023 | $14,525 | -79.8% | 3,144 | -64.0% | 0.00% | – |
| Q1 2022 | $72,000 | +94.6% | 8,740 | +251.3% | 0.00% | – |
| Q4 2021 | $37,000 | -28.8% | 2,488 | -9.2% | 0.00% | – |
| Q3 2021 | $52,000 | +4.0% | 2,741 | +2.5% | 0.00% | – |
| Q2 2021 | $50,000 | -15.3% | 2,674 | +4.0% | 0.00% | – |
| Q1 2021 | $59,000 | – | 2,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $33,918,000 | 14.78% |
| Samsara BioCapital, LLC | 1,675,579 | $31,149,000 | 3.84% |
| First Light Asset Management, LLC | 2,072,875 | $38,535,000 | 2.31% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,253,000 | 1.88% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $18,616,000 | 1.72% |
| Opaleye Management Inc. | 496,900 | $9,237,000 | 1.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,590,000 | 0.68% |
| Parkman Healthcare Partners LLC | 163,389 | $3,037,000 | 0.66% |
| Eventide Asset Management | 2,370,975 | $44,076,000 | 0.59% |
| BVF INC/IL | 826,825 | $15,371,000 | 0.58% |